Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Improved Surfactant-Assisted One-Pot Sample Preparation for Robust Convenient Single-Cell Proteomics.

Journal of proteome research·2026
Same author

KCTD3 deficiency disrupts axon initial segment organization and neurite outgrowth in a neurodevelopmental disorder mouse model.

Communications biology·2026
Same author

Interlaboratory Comparison of a Glucagon and Oxyntomodulin Immuno-LC-MS/MS Assay: Implications for Diabetes Research.

Clinical chemistry·2026
Same author

A multiplexed targeted mass spectrometric assay for quantifying obesity- associated biomarkers in human plasma.

Research square·2026
Same author

Assessing current capabilities for incorporating lipidomics in multiomics data integration.

Briefings in bioinformatics·2026
Same author

Probiotic Bifidobacterium bifidum BGN4 supplementation modulates gut microbiome composition and reduces circulating zonulin, TNFα, and insulin in adults with excess adiposity: a randomized, double-blind, placebo-controlled trial.

Nutrition & metabolism·2026

相关实验视频

Updated: Jun 20, 2025

Phosphopeptide Enrichment Coupled with Label-free Quantitative Mass Spectrometry to Investigate the Phosphoproteome in Prostate Cancer
12:23

Phosphopeptide Enrichment Coupled with Label-free Quantitative Mass Spectrometry to Investigate the Phosphoproteome in Prostate Cancer

Published on: August 2, 2018

12.1K

在前列腺癌生物标志物发展中的多重复合量化蛋白质组学.

Yuqian Gao1, Hyeyoon Kim1, Reta Birhanu Kitata1

  • 1Biological Sciences Division, Pacific Northwest National Laboratory, Richland, WA, United States.

Advances in cancer research
|July 20, 2024
PubMed
概括

新的蛋白质组学技术可以改善前列腺癌 (PCa) 检测,而不仅仅是前列腺特异性抗原 (PSA). 这些先进的方法通过分析各种样本的新型蛋白质生物标志物来识别积极的PCa并减少过度处理.

关键词:
时间 时间 时间 时间早期检测 早期检测在PRM中,PRM是PRM.前列腺癌是什么意思 前列腺癌是什么意思蛋白质生物标志物是一种蛋白质生物标志物.风险分层是指风险的分层.在SRM中,我们可以使用SRM.

更多相关视频

Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors
08:08

Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors

Published on: February 27, 2015

16.1K
Quantitation of Protein Expression and Co-localization Using Multiplexed Immuno-histochemical Staining and Multispectral Imaging
08:40

Quantitation of Protein Expression and Co-localization Using Multiplexed Immuno-histochemical Staining and Multispectral Imaging

Published on: April 8, 2016

12.8K

相关实验视频

Last Updated: Jun 20, 2025

Phosphopeptide Enrichment Coupled with Label-free Quantitative Mass Spectrometry to Investigate the Phosphoproteome in Prostate Cancer
12:23

Phosphopeptide Enrichment Coupled with Label-free Quantitative Mass Spectrometry to Investigate the Phosphoproteome in Prostate Cancer

Published on: August 2, 2018

12.1K
Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors
08:08

Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors

Published on: February 27, 2015

16.1K
Quantitation of Protein Expression and Co-localization Using Multiplexed Immuno-histochemical Staining and Multispectral Imaging
08:40

Quantitation of Protein Expression and Co-localization Using Multiplexed Immuno-histochemical Staining and Multispectral Imaging

Published on: April 8, 2016

12.8K

科学领域:

  • 在瘤学瘤学.
  • 蛋白质组学是指蛋白质组学.
  • 生物标志物发现发现

背景情况:

  • 前列腺癌 (PCa) 是美国男性的主要癌症.
  • 目前的生物标志物,如前列腺特异性抗原 (PSA),在检测侵袭性疾病方面存在局限性,可能导致过度治疗.
  • 改善蛋白质生物标志物对于准确的PCa诊断和管理至关重要.

研究的目的:

  • 为前列腺癌 (PCa) 生物标志物开发提供最先进的蛋白质组学技术的概述.
  • 审查提高蛋白质检测灵敏度和丰富特定分子信息的方法.
  • 总结最近对新型PCa蛋白生物标记物的验证研究.

主要方法:

  • 基于液体染色学和质谱学 (LC-MS) 的蛋白质组学.
  • 蛋白质/丰富策略 (基于抗体和独立) 对于低丰度蛋白质.
  • 丰富翻译后的修改 (例如,糖化) 和细胞外囊泡.
  • 先进的数据采集方法,以提高准确性和吞吐量.

主要成果:

  • 在检测低丰度蛋白质和特定修改方面取得的进展.
  • 在各种样本类型 (细胞系,组织,生物流体,血液) 中成功应用蛋白质组学技术.
  • 开发用于PCa的各种临床应用的新型蛋白质生物标志物.

结论:

  • 先进的蛋白质组学技术为改善前列腺癌 (PCa) 生物标志物发现提供了显著的潜力.
  • 这些方法提高了灵敏度和特异性,使得更好地检测出侵袭性PCa.
  • 通过这些技术开发的新型蛋白质生物标志物可以帮助早期诊断,预后和治疗干预.